The H1N1 "swine" flu coverage continues on this blog. Now according to Bloomberg, it will be okay for vaccine makers to use adjuvants in the H1N1 "swine" flu vaccine. I recall hearing that adjuvants have been linked to various neurological, autoimmune disorders.
Swine flu vaccine makers may rely on a U.S. emergency declaration to use experimental additives made by GlaxoSmithKline Plc and Novartis AG to boost a limited supply of shots...
[A]djuvants, may be added for the first time to flu shots in the U.S. Health officials, meeting today at the U.S. Centers for Disease Control and Prevention in Atlanta, plan to discuss use of the additives...
I will do further research and post my findings, but I would not trust these additives or vaccines. If these adjuvants cause a superboost to the immune system, then it leads me to believe that these additives may be one cause of the numerous autoimmune diseases affecting our population. Too much of a particular vaccine with these experimental adjuvants could potentially cause the body to turn its defenses on itself.
You may be asking yourself -- what in the world are "adjuvants?" I crtainly was not aware of these ingredients until the last couple of days. Wow, this rabbit hole never ends!
Luckily, all the people are not sheep to the pro-vaccine propaganda.
You may be asking yourself -- what in the world are "adjuvants?" I crtainly was not aware of these ingredients until the last couple of days. Wow, this rabbit hole never ends!
The adjuvants are mixes of oil and water that -- by stimulating the immune system -- offer a way to boost the body’s response to antigen. Adjuvants, whose effectiveness vary by flu strain, may boost the strength of the antigen as much as 10- fold.
Luckily, all the people are not sheep to the pro-vaccine propaganda.
“Until GlaxoSmithKline and Novartis can show me it won’t harm a rat or guinea pig, I think it’s a bad idea to give it to humans,” Vicky Debold, a registered nurse with a Ph.D. in public health, who is a member of the FDA’s advisory committee for reviewing vaccines, said July 27 in an interview.
Source: Bloomberg
No comments:
Post a Comment